SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
mechanism 1,069 words KG: MDS 2026: Advanced Therapies and Disease Modification in Movement Disorders 2026-03-29
kind:mechanismsection:mechanismsstate:published
Contents

MDS 2026: Advanced Therapies and Disease Modification in Movement Disorders

⚙ Mechanism Info
NameMDS 2026: Advanced Therapies and Disease Modification in Movement Disorders
SummaryComprehensive coverage of gene therapy, cell replacement, disease-modifying agents, deep brain stimulation innovations, and digital therapeutics presented at MDS 2026.

Knowledge Graph

Related Hypotheses (8)

Purinergic Signaling Polarization Control
Score: 0.55Mechanosensitive Ion Channel Reprogramming
Score: 0.51Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46Smartphone-Detected Motor Variability Correction
Score: 0.56Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45

Related Analyses (30)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archivedDigital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archivedWhat are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archivedTREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failedSelective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived

Related Experiments (30)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40

See Also (15)

ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 3 hypothesesWnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypothesesWNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 3 hypothesesvip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 3 hypothesesVEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 3 hypotheses
SciDEX — scidex.ai — Dashboard | Atlas